Page last updated: 2024-08-24

valsartan and Acute Respiratory Distress Syndrome

valsartan has been researched along with Acute Respiratory Distress Syndrome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Al-Gareeb, AI; Al-Kuraishy, HM; Alexiou, A; Batiha, GE	1
Aarts, GWA; Bresser, P; Cornel, JH; Cortenbach, K; de Jager, CPC; de Leeuw, PW; Gommans, DHF; Hassing, RJ; Konijnenberg, LSF; Konst, RE; Koop, Y; Mensink, F; Mol, JQ; Nas, J; Pinto, YM; Pinto-Sietsma, SJ; Rooijakkers, MJP; Thannhauser, J; Tijssen, JGP; van Agtmael, MA; van den Heuvel, MM; van der Hoeven, HG; van Gilst, WH; van Kimmenade, RRJ; van Royen, N; van Rumund, A; Vart, P; Verbon, A; Verhaert, DVM; Vonk-Noordergraaf, A; Vos, JL	1

Studies

Al-Gareeb, AI; Al-Kuraishy, HM; Alexiou, A; Batiha, GE

Aarts, GWA; Bresser, P; Cornel, JH; Cortenbach, K; de Jager, CPC; de Leeuw, PW; Gommans, DHF; Hassing, RJ; Konijnenberg, LSF; Konst, RE; Koop, Y; Mensink, F; Mol, JQ; Nas, J; Pinto, YM; Pinto-Sietsma, SJ; Rooijakkers, MJP; Thannhauser, J; Tijssen, JGP; van Agtmael, MA; van den Heuvel, MM; van der Hoeven, HG; van Gilst, WH; van Kimmenade, RRJ; van Royen, N; van Rumund, A; Vart, P; Verbon, A; Verhaert, DVM; Vonk-Noordergraaf, A; Vos, JL

Trials

1 trial(s) available for valsartan and Acute Respiratory Distress Syndrome

Article	Year
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease. American heart journal, 2020, Volume: 226 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Betacoronavirus; Coronary Care Units; Coronavirus Infections; COVID-19; Double-Blind Method; Drug Administration Schedule; Humans; Inpatients; Multicenter Studies as Topic; Netherlands; Pandemics; Placebos; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Time Factors; Valsartan	2020

Article

Year

Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease.

American heart journal, 2020, Volume: 226

Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Betacoronavirus; Coronary Care Units; Coronavirus Infections; COVID-19; Double-Blind Method; Drug Administration Schedule; Humans; Inpatients; Multicenter Studies as Topic; Netherlands; Pandemics; Placebos; Pneumonia, Viral; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Distress Syndrome; SARS-CoV-2; Time Factors; Valsartan

2020

Other Studies

1 other study(ies) available for valsartan and Acute Respiratory Distress Syndrome

Article	Year
Targeting and Modulation of the Natriuretic Peptide System in Covid-19: A Single or Double-Edged Effect? Current protein & peptide science, 2022, Volume: 23, Issue:5 Topics: Aldosterone; Aminobutyrates; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Cathepsin G; COVID-19 Drug Treatment; Cytokines; Gastrin-Releasing Peptide; Heart Failure; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Neprilysin; Renin; Respiratory Distress Syndrome; Tetrazoles; Valsartan	2022

Article

Year

Targeting and Modulation of the Natriuretic Peptide System in Covid-19: A Single or Double-Edged Effect?

Current protein & peptide science, 2022, Volume: 23, Issue:5

Topics: Aldosterone; Aminobutyrates; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Biphenyl Compounds; Cathepsin G; COVID-19 Drug Treatment; Cytokines; Gastrin-Releasing Peptide; Heart Failure; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Neprilysin; Renin; Respiratory Distress Syndrome; Tetrazoles; Valsartan

2022